Evidence map›Paper›PMID 34980111›Full record

ArticleBMC health services research2022

Capitated versus fee-for-service reimbursement and quality of care for chronic disease: a US cross-sectional analysis.

Sri Lekha Tummalapalli, Michelle M Estrella, Deanna P Jannat-Khah, Salomeh Keyhani, Said Ibrahim

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. General practice incentives: a review of the international literature.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Pooled it
  2. Conversion to Arthroscopic Surgery for Anterior Shoulder Instability Does Not Significantly Increase Patient Out-of-Pocket Costs, But Both Conversion and Initial Arthroscopic Management Are Twice as Costly as Isolated Nonoperative Management.Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sri Lekha TummalapalliDivision of Healthcare Delivery Science & Innovation, Department of Population Health Sciences, Weill Cornell Medicine, 402 East 67th Street, New York, NY, 10065, USA. lct4001@med.cornell.edu.ORCID http://orcid.org/0000-0002-6513-8460
Michelle M EstrellaKidney Health Research Collaborative, Department of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA, USA.
Deanna P Jannat-KhahDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA.
Salomeh KeyhaniDivision of General Internal Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Said IbrahimDivision of Healthcare Delivery Science & Innovation, Department of Population Health Sciences, Weill Cornell Medicine, 402 East 67th Street, New York, NY, 10065, USA.
San Francisco VA Medical Center · USCornell University · USHospital for Special Surgery · US

Funding

Screening Strategies for Chronic Kidney Disease in US PopulationsF32DK122627 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI TUMMALAPALLI, SRI LEKHA · 2019 to 2021
$159k
NIDDK NIH HHS F32 DK122627NIDDK NIH HHS F32DK122627
6 · The paper itself

Abstract

backgroundUpcoming alternative payment models Primary Care First (PCF) and Kidney Care Choices (KCC) incorporate capitated payments for chronic disease management. Prior research on the effect of capitated payments on chronic disease management has shown mixed results. We assessed the patient, physician, and practice characteristics of practices with capitation as the majority of revenue, and evaluated the association of capitated reimbursement with quality of chronic disease care.

methodsWe performed a cross-sectional analysis of visits in the United States' National Ambulatory Medical Care Survey (NAMCS) for patients with hypertension, diabetes, or chronic kidney disease (CKD). Our predictor was practice reimbursement type, classified as 1) majority capitation, 2) majority FFS, or 3) other reimbursement mix. Outcomes were quality indicators of hypertension control, diabetes control, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker (ACEi/ARB) use, and statin use.

resultsAbout 9% of visits were to practices with majority capitation revenue. Capitated practices, compared with FFS and other practices, had lower visit frequency (3.7 vs. 5.2 vs. 5.2, p = 0.006), were more likely to be located in the West Census Region (55% vs. 18% vs. 17%, p < 0.001), less likely to be solo practice (21% vs. 37% vs. 35%, p = 0.005), more likely to be owned by an insurance company, health plan or HMO (24% vs. 13% vs. 13%, p = 0.033), and more likely to have private insurance (43% vs. 25% vs. 19%, p = 0.004) and managed care payments (69% vs. 23% vs. 26%, p < 0.001) as the majority of revenue. The prevalence of controlled hypertension, controlled diabetes, ACEi/ARB use, and statin use was suboptimal across practice reimbursement types. Capitated reimbursement was not associated with differences in hypertension, diabetes, or CKD quality indicators, in multivariable models adjusting for patient, physician, and practice characteristics.

conclusionsPractices with majority capitation revenue differed substantially from FFS and other practices in patient, physician, and practice characteristics, but were not associated with consistent quality differences. Our findings establish baseline estimates of chronic disease quality of care performance by practice reimbursement composition, informing chronic disease care delivery within upcoming payment models.

Indexed as

Angiotensin Receptor AntagonistsFee-for-Service PlansAngiotensin-Converting Enzyme InhibitorsCapitation FeeChronic DiseaseCross-Sectional StudiesHumansUnited StatesAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCapitationChronic diseaseChronic kidney diseaseDiabetesFee-for-serviceHealth services researchHypertensionPhysician reimbursement

Identifiers

PMID34980111
PMCPMC8723903
OpenAlexW4206698967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.